about
Neuroprotection mediated by inhibition of calpain during acute viral encephalitisThe PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral DrugsHIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentRole of HIV in amyloid metabolismRole of neuroimaging in HIV-associated neurocognitive disordersEfavirenz and the CNS: what we already know and questions that need to be answeredNeurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapyMorphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neuritesEffect of secondary preventive therapy on recurrence of tuberculosis in HIV-infected individuals: a systematic review.Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.Neuroimaging of HIV-associated neurocognitive disorders (HAND)PET brain imaging in HIV-associated neurocognitive disorders (HAND) in the era of combination antiretroviral therapy.HIV-associated neurocognitive disorder.Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditionsHost genetic factors predisposing to HIV-associated neurocognitive disorder.Early suppressive antiretroviral therapy in HIV infection is associated with measurable changes in the corpus callosum.Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravir.Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort study.When to start antiretroviral therapy: the need for an evidence base during early HIV infectionControversies in HIV-associated neurocognitive disordersNeurocognitive functioning in a Romanian cohort of young adults with parenterally-acquired HIV-infection during childhood.Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART.HIV eradication symposium: will the brain be left behind?Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort studyThe effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India.Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.Evaluation of a Cognitive Rehabilitation Protocol in HIV Patients with Associated Neurocognitive Disorders: Efficacy and Stability Over Time.A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals.Effect of HAART on Brain Organization and Function in HIV-Negative SubjectsAntiretrovirals, Methamphetamine, and HIV-1 Envelope Protein gp120 Compromise Neuronal Energy Homeostasis in Association with Various Degrees of Synaptic and Neuritic DamageHIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance.Human immunodeficiency virus has similar effects on brain volumetrics and cognition in males and females.Sex and HIV serostatus differences in decision making under risk among substance-dependent individuals.Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patientsEnhanced antagonism of BST-2 by a neurovirulent SIV envelopeEnhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugsAn investigation of the effects of antiretroviral central nervous system penetration effectiveness on procedural learning in HIV+ drug usersApplications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection.Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous systemAntiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children
P2860
Q26700065-C6381FD5-BEA8-45D1-9A0C-0BF8C9B4727CQ26744617-91923673-2300-4CCB-8CD1-1A3207FEF78EQ26766448-1ACB5679-9F57-492A-8A78-BAE5EFEE2276Q26824179-6E28EAF7-4FBF-42C4-8DDE-3A21F97DF7FFQ26852705-43ED2C48-29F8-4D8E-A2F6-F0E2E9134BD3Q28085028-F48E82C2-2C7E-4BDD-89E1-A2B60CCE098BQ28534903-44F95F4E-D8BA-4524-A197-635703EA1747Q28539889-CC597E46-F4BD-48E1-A445-0EC630CDF4A5Q30240445-5BB52BE6-40F8-4115-A538-EA19BFD7B966Q30834094-785D5F6B-19A2-4329-90DA-AD7A38F73CB9Q30854917-5D4D7EFE-ADC7-48C2-A2ED-1810F649BB8CQ31153188-CE92914B-54C3-4BAB-AF84-1D7B30CA4325Q33939729-18AADA5A-4829-4E2D-AF19-E467A1DBB25BQ33980117-5FBA5516-D726-4C43-A83C-68D632874147Q34001122-63843385-BA7B-4362-AFF2-563873693C44Q34389419-A2F19AA9-28E9-4A69-9BF2-82D7B3BD55FDQ34485748-A9251BFF-7C8A-4FFD-9CFD-79EE06F35892Q34756398-5730EC58-B162-488E-B7C6-E85301BEC600Q34773308-8632917B-0F7B-49E7-B726-2AE63A887475Q35037015-5CC1C49B-4EB8-44F4-9205-8F25DE234029Q35073479-5BE01C71-C0A9-4007-B6C4-1B02588BA124Q35568896-8DA0963D-C2F9-44F5-9D53-D8F92D621126Q35607587-D4E1D82B-EDF9-41D0-B15A-5A7C48FAAFA0Q35794099-C6AB2F0E-8C39-41EA-9F4B-B8466A6309AEQ35883236-3939D9FA-8410-497E-BBE1-EDB37F0CD759Q36169735-5138B73A-BBCC-4EA5-AB3C-02EEE902C961Q36280225-25D2C265-35CD-43C3-A8CB-1478A967A7C7Q36293999-CEE75877-884D-4B7B-96D3-88FC7B7C0F60Q36326853-E41263D5-1171-4EF8-8750-96F7912ADF74Q36439056-FFFD07F8-7CD6-4AD2-B64D-43CC2257AF92Q36517668-94817393-95BD-40DE-B53E-B6A0869FECD5Q36520471-70DF1F38-70BF-41C2-A691-6FA5715A927EQ36602745-B7E350E9-4086-4D6D-941F-D58C26C72B6EQ36664960-47D36B31-38E9-47D2-935F-4C4E637D6C62Q36951741-554C7714-5205-41FA-89CA-4B20EEA1619AQ37018003-6F959701-9B81-40B8-8593-DE08962807E8Q37375961-F1103F72-502A-4F35-B78C-63F0CCFF26BBQ37467991-6A2C7C18-F815-4C6E-ADDF-6FC677952733Q37592018-3ABE14CD-3B94-4627-8989-64FD88FB58CFQ37691000-E35AA756-6368-429B-A766-F8D38071495E
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Antiretroviral neurotoxicity
@ast
Antiretroviral neurotoxicity
@en
type
label
Antiretroviral neurotoxicity
@ast
Antiretroviral neurotoxicity
@en
prefLabel
Antiretroviral neurotoxicity
@ast
Antiretroviral neurotoxicity
@en
P2093
P2860
P1476
Antiretroviral neurotoxicity
@en
P2093
Jeff Liner
Kevin Robertson
Rick B Meeker
P2860
P2888
P304
P356
10.1007/S13365-012-0120-3
P577
2012-07-19T00:00:00Z